Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 72603-623

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 72603-623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

198 (Lurasidone Fig 1)

A pharmacokinetic chart titled "Impact of other drugs on Lurasidone Pharmacokinetics (PK)" showing fold change and 90% confidence intervals for various interacting drugs. The x-axis represents change relative to lurasidone alone, ranging from -4 to 4. The chart compares Cmax and AUC for strong and moderate CYP3A4 inhibitors and inducers, including ketoconazole, diltiazem, rifampin, and lithium, illustrating their impact on lurasidone levels.*

FDA Label Image

111 (Lurasidone Fig 2)

A forest plot showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, Ctrough) of various interacting drugs including P-gp substrates (Digoxin 0.25 mg SD), CYP3A4 substrates (Midazolam 5 mg SD), oral contraceptives (Ethinyl Estradiol, Norelgestromin), and Lithium 600 mg BID. The x-axis represents change relative to the interactive drug alone, ranging from -1.0 to 1.0.*

FDA Label Image

122 (Lurasidone Fig 3)

A pharmacokinetic (PK) chart depicting fold change and 90% confidence intervals (CI) for lurasidone hydrochloride in populations with varying degrees of renal and hepatic impairment, as well as in subgroups described by gender and race. The x-axis shows change relative to reference, with data points for Cmax and AUC across mild, moderate, and severe impairment levels, and population subgroups including females and Asian race.*

FDA Label Image

115 (Lurasidone Structure)

Chemical structure of lurasidone hydrochloride showing its molecular arrangement including multiple rings and functional groups, along with the hydrochloride component indicated.*

FDA Label Image

889 (Lurasidone Tablets 20 mg 30s)

Label for Lurasidone Hydrochloride Tablets 20 mg by NorthStar Rx LLC. The label indicates the product is Rx only, comes in a 30 tablet count, and each film-coated tablet contains 20 mg of lurasidone hydrochloride. Storage instructions and barcode are included, along with manufacturer details: Macleods Pharmaceuticals Ltd, India.*

FDA Label Image

778 (Lurasidone Tablets 40 mg 30s)

Label for Lurasidone Hydrochloride Tablets 40 mg, film coated, with a package size of 30 tablets. The label includes NDC 72603-622-01 and states the active ingredient amount per tablet as 40 mg (equivalent to 37.24 mg of lurasidone). It provides storage instructions and manufacturer details, listing NorthStar Rx LLC as the labeler and Macleods Pharmaceuticals Ltd. as the manufacturer in India.*

FDA Label Image

008 (Lurasidone Tablets 60 mg 30s)

Label for Lurasidone Hydrochloride Tablets 60 mg film coated tablets. The label displays the NDC 72603-623-01, the strength 60 mg, and the package count of 30 tablets. It includes storage instructions, mentions the medication guide, and identifies NorthStar Rx LLC as the labeler with manufacturing by Macleods Pharmaceuticals Ltd in India.*

FDA Label Image

897 (Lurasidone Tablets 80 mg 30s)

The label for Lurasidone Hydrochloride Tablets 80 mg film-coated oral tablets by NorthStar Rx LLC displays the NDC 72603-624-01, with a 30 tablet count. It includes dosing and storage information, barcode, manufacturer details including Macleods Pharmaceuticals Ltd. and Oxalis Labs, and directions for pharmacists to dispense the medication guide with each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.